February 16, 2022
PAR-21-155 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is the inform applicants of a change to the IC-specific interests for NINDS for Funding Opportunity Announcement (FOA) PAR-21-155 "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)". Changes to FOA are shown below.
Currently Reads:
Part 2. Full Text of Announcement
Funding Opportunity Description:
NCI considers meritorious R15 applications requesting support for cancer research-focused projects across the full spectrum of its mission, including projects focused on studies of cancer biology, etiology, prevention, detection, diagnosis, treatment, control, survivorship, and population sciences. The NCI R15 Program Contact person (indicated below) can be contacted for more information and guidance about NCI’s mission, priorities, and interests as related to the R15 Program, this R15 funding opportunity announcement, and R15 applications.
NINDS seeks fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. NINDS supports basic, translational and clinical research within specifically defined areas of neuroscience. Research projects considered for funding by NINDS must fall within the scientific research mission of the Institute. A key component of research projects submitted to NINDS in response to this FOA is to provide an outstanding opportunity for undergraduates to gain a solid understanding of rigorous scientific methodology within the particular field of study. NINDS also strongly urges PIs to engage students from diverse backgrounds and perspectives in their research project. For this FOA, projects are limited to prospective basic science studies involving human participants that fall within the broad NIH definition of a clinical trial and also meet the definition of basic research as described in NOT-OD-18-212. It is critical that applicants with research interests relevant to the NINDS mission contact the person listed under Agency Contacts (Section VII) to confirm that the proposed clinical trial meets NINDS’ requirements for this funding opportunity.
In addition, applicants are encouraged to consult the Frequently Asked Questions website and the NIH Research Enhancement Award R15 website for more information about this program
Modified to Read:
Part 2. Full Text of Announcement
Funding Opportunity Description:
NCI considers meritorious R15 applications requesting support for cancer research-focused projects across the full spectrum of its mission, including projects focused on studies of cancer biology, etiology, prevention, detection, diagnosis, treatment, control, survivorship, and population sciences. The NCI R15 Program Contact person (indicated below) can be contacted for more information and guidance about NCI’s mission, priorities, and interests as related to the R15 Program, this R15 funding opportunity announcement, and R15 applications.
NINDS seeks fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. NINDS supports basic, translational and clinical research within specifically defined areas of neuroscience. Research projects considered for funding by NINDS must fall within the scientific research mission of the Institute. A key component of research projects submitted to NINDS in response to this FOA is to provide an outstanding opportunity for undergraduates to gain a solid understanding of rigorous scientific methodology within the particular field of study. NINDS also strongly urges PIs to engage students from diverse backgrounds and perspectives in their research project. It is critical that applicants with research interests relevant to the NINDS mission contact the person listed under Agency Contacts (Section VII) to confirm that the proposed clinical trial meets NINDS’ requirements for this funding opportunity.
In addition, applicants are encouraged to consult the Frequently Asked Questions website and the NIH Research Enhancement Award R15 website for more information about this program
All other aspects of this FOA remain unchanged.
Delany Torres, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301- 402-9286
Email: [email protected]
and Human Services (HHS)
